Amplex enters into additional agreements on conditional acquisitions of shares and warrants in ADDvise

Amplex AB has increased its cash offer for ADDvise Group AB to SEK 1.72 per A/B share and SEK 0.52 per warrant and announced additional conditional acquisition agreements that, together with prior undertakings and Amplex-controlled shares, represent approximately 56.65% of ADDvise’s share capital and ~64.42% of votes. The new agreements cover holders controlling ~3.85% of capital and ~5.15% of votes and are conditional on regulatory approvals (including the Swedish Inspectorate of Strategic Products) and a top-up payment; settlement is expected at the first offer settlement but no later than 20 March 2026. Nordea and Linklaters advise Amplex.

Analysis

Market structure: Amplex’s conditional agreements push its control stake to ~56.65% of share capital and ~64.42% of votes, making a successful squeeze-out materially more likely and reducing public free float. Winners are Amplex (control, strategic optionality), selling shareholders accepting SEK 1.72/A-share and SEK 0.52/warrant; losers are remaining minority holders facing illiquidity and limited price discovery. Liquidity will compress, bid-ask spreads widen, and peer small‑cap Swedish industrial/life‑science trading volumes may pick up as arbitrageurs deploy capital.

Risk assessment: The principal tail risk is regulatory blockage by the Swedish Inspectorate of Strategic Products or other export-control/sanctions hurdles — assign a working probability of 15–30% given conditional language; financing/solvency of Amplex and a competing bid are secondary tail risks (10–20%). Short horizon (days–weeks): market will trade on rumor/acceptance flows; medium (weeks–months): permit decisions and first settlement (no later than 20 Mar 2026) drive value; long (quarters): delisting or operational turnarounds determine ultimate returns. Hidden dependency: the “top‑up payment” clause and Amplex’s ability to buy outside the offer create execution and timing optionality.

Trade implications: Direct play — establish a small arbitrage long in ADDvise if shares trade ≥10% below SEK 1.72 (i.e., <SEK 1.55) sized 2–5% NAV with target close at settlement (by 20 Mar 2026) and hard stop at a 20% loss or regulatory-rejection trigger. If the share trades >5% above SEK 1.72 (i.e., >SEK 1.81) short to capture reversion to offer price, close within 30 days. Options — where available, buy puts (30–90d) to hedge downside or sell covered calls after establishing long; consider call spreads if you expect a competing bid >SEK 1.90.

Contrarian angles: Consensus may underprice the path‑to‑control: with >56% committed, probability of deal close may be >70% despite regulatory noise, implying current discounts could be overstated. Conversely, the market may be underestimating the illiquidity premium post-close (2–5% upward pressure on private valuation) and warrant dilution complexity; historical Swedish small‑cap takeovers with similar control thresholds closed >70% of the time within three months, so take skewed, size‑limited risk-on positions rather than full conviction longs.

Key Decisions for Investors

• If ADDvise shares trade below SEK 1.55, consider establishing a 2–5% NAV long position (arbitrage) with a target exit at SEK 1.72 upon settlement (no later than 20 Mar 2026); implement a stop-loss at SEK 1.24 (20% downside) or immediate exit if Inspectorate signals rejection.
• If ADDvise shares trade above SEK 1.81, open a short position sized 1–3% NAV to capture mean reversion to SEK 1.72; cover within 30 days or upon announcement of a competing bid or permit approval.
• For holders of ADDvise warrants (TO1A/TO1B), compare market warrant price to SEK 0.52 intrinsic — if warrants are trading >30% rich to 0.52, sell/hedge; if trading >30% cheap, buy a small position anticipating arbitrage at settlement (size 0.5–2% NAV).
• Hedge portfolio exposure: buy 30–90 day SEK put vs EUR or increase cash in SEK-denominated small-cap exposure by up to 1–2% if regulatory developments look adverse in the next 30–60 days; conversely, add 1% tactical exposure to Swedish small‑cap M&A names if multiple aggressive bids appear.
• Monitor three catalysts on a 0–60 day cadence: (1) Inspectorate decision (binary, highest impact), (2) any competing bid priced >SEK 1.90 (probability threshold >30% to increase long size), (3) Amplex disclosure of financing/market purchases (if Amplex buys >5% in market, increase confidence and reduce hedge).